Trial · NCT02498652
Results by group95
Each measurement the trial posted, group by group, in the words and numbers it posted.
41 to 60 of 95
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time of Occurrence of Maximum Observed Concentration (Tmax) | Treatment A2q | 2.98 | 95% Confidence Interval 0.983 to 4.00 | hr | |
| Time of Occurrence of Maximum Observed Concentration (Tmax) | Treatment A2b | 2.02 | 95% Confidence Interval 0.500 to 8.00 | hr | |
| Time of Occurrence of Maximum Observed Concentration (Tmax) | Treatment R1 | 2.01 | 95% Confidence Interval 0.967 to 6.00 | hr | |
| Time of Occurrence of Maximum Observed Concentration (Tmax) | Treatment R2 | 2.49 | 95% Confidence Interval 0.500 to 3.97 | hr | |
| Time of Occurrence of Maximum Observed Concentration (Tmax) | Treatment R3 | 1.73 | 95% Confidence Interval 0.500 to 6.00 | hr | |
| Time of Occurrence of Maximum Observed Concentration (Tmax) | Treatment R4 | 2.98 | 95% Confidence Interval 0.500 to 6.02 | hr | |
| Time of Occurrence of Maximum Observed Concentration (Tmax) | Treatment R5 | 1.73 | 95% Confidence Interval 0.500 to 6.00 | hr | |
| Time of Occurrence of Maximum Observed Concentration (Tmax) | Treatment R6 | 1.97 | 95% Confidence Interval 0.500 to 4.03 | hr | |
| Area Under the Concentration-time Curve From Time Zero up to 24 Hours Postdose (AUC 0-24) | Treatment A1 | 3.94 | 95% Confidence Interval 3.52 to 4.42 | µg·hr/mL | |
| Area Under the Concentration-time Curve From Time Zero up to 24 Hours Postdose (AUC 0-24) | Treatment A2q | 11.0 | 95% Confidence Interval 8.87 to 13.7 | µg·hr/mL | |
| Area Under the Concentration-time Curve From Time Zero up to 24 Hours Postdose (AUC 0-24) | Treatment A2b | 8.64 | 95% Confidence Interval 7.13 to 10.5 | µg·hr/mL | |
| Area Under the Concentration-time Curve From Time Zero up to 24 Hours Postdose (AUC 0-24) | Treatment R1 | 4.06 | 95% Confidence Interval 3.24 to 5.10 | µg·hr/mL | |
| Area Under the Concentration-time Curve From Time Zero up to 24 Hours Postdose (AUC 0-24) | Treatment R2 | 4.10 | 95% Confidence Interval 3.53 to 4.77 | µg·hr/mL | |
| Area Under the Concentration-time Curve From Time Zero up to 24 Hours Postdose (AUC 0-24) | Treatment R3 | 3.81 | 95% Confidence Interval 3.13 to 4.64 | µg·hr/mL | |
| Area Under the Concentration-time Curve From Time Zero up to 24 Hours Postdose (AUC 0-24) | Treatment R4 | 3.83 | 95% Confidence Interval 3.15 to 4.65 | µg·hr/mL | |
| Area Under the Concentration-time Curve From Time Zero up to 24 Hours Postdose (AUC 0-24) | Treatment R5 | 3.88 | 95% Confidence Interval 3.15 to 4.77 | µg·hr/mL | |
| Area Under the Concentration-time Curve From Time Zero up to 24 Hours Postdose (AUC 0-24) | Treatment R6 | 3.82 | 95% Confidence Interval 3.27 to 4.46 | µg·hr/mL | |
| Area Under the Concentration-time Curve From Time Zero to the Last Quantifiable Sampling Timepoint (AUC Last) | Treatment A1 | 3.70 | 95% Confidence Interval 3.28 to 4.18 | µg·hr/mL | |
| Area Under the Concentration-time Curve From Time Zero to the Last Quantifiable Sampling Timepoint (AUC Last) | Treatment A2q | 10.9 | 95% Confidence Interval 8.74 to 13.5 | µg·hr/mL | |
| Area Under the Concentration-time Curve From Time Zero to the Last Quantifiable Sampling Timepoint (AUC Last) | Treatment A2b | 4.25 | 95% Confidence Interval 3.57 to 5.07 | µg·hr/mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02498652/results?page=3